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Abstract
Purpose To establish whether objective measurements of
symmetry of volume and shape using three-dimensional
surface imaging (3D-SI) can be used as surrogate markers
of aesthetic outcome in patients who have undergone breast
conserving therapy (BCT).
Methods Women who had undergone unilateral BCT in
the preceding 1–6 years were invited to participate. Par-
ticipants completed a satisfaction questionnaire (BREAST-
Q) and underwent 3D-SI. Volume and surface symmetry
were measured on the images. Assessment of aesthetic
outcome was undertaken by a panel of clinicians. The
Kruskal–Wallis test was used to assess the relationship
between volume and shape symmetry measurements with
the panel score. Spearman’s rho correlations were used to
assess the relationship between the measurements and
patient satisfaction.
Results 200 women participated. Median volume symme-
try was 87% (IQR 78–93) and shape symmetry was
5.9 mm (IQR 4.2–8.0). The participants were grouped
according to panel assessment of aesthetic outcome (poor,
fair, good, excellent) and the median volume and shape
symmetry was calculated for each group. Volume sym-
metry significantly differed between the groups. Post hoc
pairwise comparisons demonstrated that these differences
existed between panel scores of fair versus good and good
versus excellent. Median shape symmetry also differed
according to patient panel groups with four significant
pairwise comparisons between poor versus good, poor
versus excellent, fair versus good and fair versus excellent.
There was a significant but weak correlation of both vol-
ume symmetry and surface asymmetry with BREAST-Q
scores (correlation coefficients 0.187 and -0.229,
respectively).
Conclusion Breast volume and shape symmetry are both
associated with panel assessment scores and patient satis-
faction. The objective volume and shape symmetry mea-
sures were strongly associated with panel assessment
scores, such that a 3D-SI tool could replace panel assess-
ment as a faster and more objective method of evaluating
aesthetic outcomes.
Keywords Breast cancer  Patient reported outcome
measures  Aesthetic outcome
Introduction
In the UK, around 30,000 women per year undergo breast
conserving treatment (BCT) for breast cancer [1]. The
combination of surgery and radiotherapy has achieved
good local control rates [2, 3] and is equivalent to mas-
tectomy. However, the technical challenges of completely
excising tumour whilst also re-shaping breast tissue to
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provide an aesthetically acceptable outcome yield variable
cosmetic results and variable patient satisfaction. There-
fore, although the long-term success of BCT is measured
primarily by local control, increased survivorship (87% at
5 years) [4], demands that the physical and psychological
effects of treatment, especially long-term effects, are
addressed. Dissatisfaction with the appearance after treat-
ment acts as a constant reminder of the disease and affects
a woman’s psychological wellbeing [5–7].
Assessment of aesthetic outcome has, to date, remained
a challenge for breast and plastic surgeons alike. There is
no gold standard or consensus on which factors should be
assessed and who should undertake the analysis [8]. The
mainstays of assessment are subjective, using either
patient-reported outcome measures (PROMs) [9–12] or
panel assessment of appearance [13, 14]. More recently,
objective assessments have been developed in the form of
the Breast Analysing Tool (BAT) [15] and the Breast
Cancer Conservative Treatment cosmetic result software
(BCCT.core) [16, 17] whereby a single photograph (ante-
rior view) of the patient is analysed to give an aesthetic
outcome score between 1 and 4.
Three-dimensional surface imaging (3D-SI) has been
used as a marketing tool in aesthetic breast surgery. Three-
dimensional (3D) images are taken and manipulated to
illustrate to potential patients how they may appear after
augmentation or mammoplasty/mastopexy. A survey of
1067 plastic surgeons in America revealed that 15% of
surgeons are using 3D-SI technology in their practice [18].
We have reported on the use of 3D-SI as a research and
clinical tool in aesthetic, oncoplastic and reconstructive
breast surgery [19] using linear distances and 3D mea-
surements such as volume and symmetry. Several other
studies have validated its use in volume measurement
[20–29] as a surgical planning tool. The aim of this study
was to establish whether symmetry of volume and shape on
3D-SI following BCT can be used as surrogate markers of
aesthetic outcome (as judged by a panel assessment or by
PROMs).
Methods
Patient recruitment
Research Ethical Committee (REC) approval was obtained
(ClinicalTrials.gov Identifier: NCT02304614). Women
aged C18 years who had undergone BCT (wide local
excision and adjuvant whole breast radiotherapy) for an
invasive or in situ carcinoma in our unit (four permanent
surgeons) between one and six years before the start of the
study met the inclusion criteria. The following patients
were excluded: those who developed recurrent (local or
distant) disease since BCT, those who had previously or
subsequently undergone surgery to the index or contralat-
eral breast and those who were unable to undergo 3D-SI
(e.g. unable to stand for 5 min).
Patients were invited to participate in the study by letter,
followed up by a telephone call. Those who agreed to
participate were offered an appointment for 3D-SI before
or after their mammogram or at another mutually conve-
nient time. The 3D-SI images were taken in the medical
photography department.
3D-SI breast imaging
Participants were imaged using the Vectra-XT 3D-SI sys-
tem with their hands on hips. Volume symmetry was cal-
culated by dividing the volume of the smaller breast by the
volume of the larger breast and converting to a percentage
value. The closer the result to 100, the more symmetrical
the breasts were in terms of volume. Shape symmetry was
calculated by bisecting the 3D image vertically along the
midline and reflecting the image of the left breast onto the
right. The root mean squared (RMS) of the distances
between the two superimposed breast surfaces was calcu-
lated in millimetres (Fig. 1). The lower the score the more
symmetrical the breasts are in terms of shape.
Panel assessment
The panel consisted of four members, two breast surgeons,
one clinical oncologist and one breast care nurse. Panellists
were asked to rate the participants’ images according to the
4-point Harvard cosmesis scale (Table 1). Initially, the
scoring system was to assess the effect of radiotherapy [13]
but has since then been adapted to a cosmetic outcome
[30]. The 3D images were rotated so that they could be
reviewed from either side, cranially looking downwards
towards the cleavage and caudally upwards from the feet
towards the inferior mammary fold (IMF). The panel
scored independently and then the opinion of the majority
was assigned as a consensus score. If there was disparity in
scoring the images, a discussion ensued to reach a con-
sensus; the method used in other studies with a cosmetic
outcome endpoint [31–33]. To evaluate the test–retest
variation, 10% of all the images were randomly shown
twice and the two scores compared.
Patient satisfaction
The BREAST-Q is a questionnaire devised by the
Memorial Sloan-Kettering Cancer Center to elicit and
quantify patient perception of outcomes after breast sur-
gery [12, 34]. It has been developed using extensive patient
input and Rasch psychometric methods [35, 36] to measure
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patient satisfaction and quality of life. Modules have been
developed for patients undergoing mastectomy, breast
reconstruction and most recently Breast Conserving Ther-
apy (BCT). This module contains eight domains. However,
only the ‘Satisfaction with breasts’ domain and some of its
sub-questions were used in this study. Each domain con-
tains sub-questions and the ‘raw’ score is transformed to a
score ranging from 0 to 100, where a higher score indicates
greater satisfaction. We have previously reported results of
all of the domains of the BREAST-Q BCT module [37].
Statistical analysis
Demographics were presented as descriptive statistics
using mean and standard deviation or median and IQR
range, as appropriate, after testing for normality. Categor-
ical data were presented as proportions and frequencies
with 95% confidence intervals (CIs) where appropriate.
The Kruskal–Wallis test was used to assess the relation-
ship between categorical (e.g. panel assessment, sub-ques-
tions from ‘Satisfaction with breasts’) and continuous
variables (e.g. volume symmetry, shape symmetry, ‘Satis-
faction with breasts’), after testing for normality. The Dunn–
Sidak test (a post hoc adjusted pairwise comparison) was
used to identify between which pairs of categorical results
the significant differences lay. Any pairwise comparisons
with a P\ 0.05 were considered statistically significant.
Spearman’s rho correlations were used to assess the
relationship between two continuous variables after testing
for normality. A correlation coefficient result between 0.00
and 0.019 indicates very weak correlation, 0.20 and 0.39 is
weak, 0.40 and 0.59 is moderate, 0.60 and 0.79 is strong
and 0.80 and 1.0 is very strong.
A kappa statistic was used for comparison of two cate-
gorical datasets. A value of 0 indicates no agreement,
0–0.20 is slight, 0.21–0.40 is fair, 0.41–0.60 is moderate,
0.61–0.80 is substantial, and 0.81–1 is almost perfect.
Analysis was undertaken using STATA (STATA, Inc.,
Texas).
Results
Between 01/04/2015 and 31/10/2015, 649 women were
scheduled to have a surveillance mammogram. Three
hundred and forty two (53.7%) women were eligible and
had a mammogram booked at a time when the investigator
(ROC) was available. All were invited but 109 were not
contactable by phone to confirm participation. Of the 233
women who were contactable, 206 (88.4%) agreed to
participate and 27 (11.6%) declined. In total, 200 (85.8%)
women participated. The clinicopathological characteris-
tics of the study population are summarised in Table 2.
Median panel score was 3 (IQR 2–4). Eight (4%) par-
ticipants were assigned a panel score of poor, 62 (31%)
scored fair, 78 (39%) scored good and 52 (26%) scored
excellent. For the 10% test–retest validation of the panel
assessment, the weighted agreement was 98.3%, Kappa
Fig. 1 Example of calculation
of shape symmetry using the
root mean squared (RMS).
Reproduced with the permission
of Canfield Scientific. The left
breast image is reflected onto
the right. In the first image a
geometric pattern is applied to
one breast image. The
perpendicular distances from all
the interception points of the
grid to the other breast is
calculated (second and third
image)
Table 1 4-Point Harvard
cosmesis scale
Outcome Description Score
Excellent Treated breast nearly identical to untreated breast. 4
Good Treated breast slightly different from untreated breast. 3
Fair Treated breast clearly different from untreated breast but not
seriously distorted.
2
Poor Treated breast seriously distorted. 1
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Table 2 Summary of study
participants’ clinicopathological
characteristics
Clinicopathological data Study population
Pre-operative data
Age at time of surgery (years), mean (SD) 64.2 (10.1)
Time from surgery to study participation (months), mean (SD) 35.6 (17.7)
Ethnic origin (%)
White 186 (93)
Non-white 14 (7)
Smoking status (%)
Never 119 (59.5)
Current 16 (8)
Ex-smoker 65 (32.5)
BMI at surgery (kg/m2), mean (SD) 27.5 (5.4)
Location of tumour on pre-operative imaging (%)
Upper outer 109 (54.5)
Central 8 (4)
Lower inner 27 (13.5)
Lower outer 21 (10.5)
Upper inner 35 (17.5)
Ultrasound size (mm), mean (SD) 13.9 (8.6)
Mammographic size (mm), mean (SD) 16.26 (10.88)
Intra-operative data
Type of surgery (%)
WLE 181 (90.5)
Other complex breast conservation 19 (9.5)
Axillary surgery (%)
Nil 19 (9.5)
SLNB or sampling 150 (75)
ALND 31 (15.5)
Re-excision of margins (%)
No 169 (84.5)
Yes 31 (15.5)
Pathology data
Tumour pathology size including DCIS (mm), mean (SD) 21.6 (13.1)
Weight of specimen (g), median (IQR) 32.5 (20–49)
Adjuvant therapy
Adjuvant chemotherapy (%)
No 161 (80.5)
Yes 39 (19.5)
Endocrine Therapy (%)
No 30 (15)
Yes 170 (85)
Whole breast radiotherapy (%)
No 0
Yes 200 (100)
Boost radiotherapy (%)
No 149 (74.5)
Yes 51 (25.5)
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0.96 (almost perfect), (P\ 0.001). Median score for
‘Satisfaction with breasts’ was 69.5 (IQR 31–100).
The median treated breast volume was 456 cm3 (IQR
323–680 cm3), median untreated breast volume was
493 cm3 (IQR 340–740 cm3). The median volume sym-
metry was 87% (IQR 78–93%) (Fig. 2). The median shape
symmetry, RMS, was 5.9 mm (IQR 4.2–8.0 mm) (Fig. 3).
Relationship of objective 3D-SI measurements
of volume and shape symmetry with panel
assessment
Volume symmetry
The median volume symmetry measurements differed
between panel assessment groups (Kruskal–Wallis test,
P = 0.028) (Table 3). Post hoc pairwise comparison using
Dunn–Sidak test further demonstrated that these differ-
ences existed between panel scores ‘fair’ and ‘good’, as
well as between ‘fair’ and ‘excellent’ (Fig. 4). Participants
deemed ‘poor’ by the panel did not have a significantly
different volume symmetry from those deemed ‘good’
(P = 0.645) or ‘excellent’ (P = 0.528). This indicates that
a ‘poor’ panel assessment did not necessarily relate to
volume symmetry but may be biased by the very small
numbers of patients in this category.
Shape symmetry
The median shape symmetry measurements differed
between panel assessment groups (Kruskal–Wallis test,
P\ 0.001) (Table 3). Post hoc pairwise comparison using
the Dunn–Sidak test further demonstrated that these dif-
ferences arose between panel scores ‘poor’ and ‘good’,
‘poor’ and ‘excellent’, ‘fair’ and ‘good’ as well as ‘fair’
and ‘excellent’ (Fig. 5). This indicates that shape symme-
try was always significantly different between those
assigned a poor or fair score and those considered to be
good or excellent.
Relationship of objective 3D-SI measurements
of volume and shape symmetry with patient
satisfaction
Volume symmetry
There was a significant positive correlation between vol-
ume symmetry measurements and ‘Satisfaction with
breasts’ scores; however, the correlation was very weak
(Spearman’s correlation coefficient = 0.187, P = 0.008,
r2 = 0.033).
Shape symmetry
There was a significant negative correlation between shape
symmetry measurements and ‘Satisfaction with breasts’
scores; however, the correlation coefficient was also weak
(Spearman’s correlation coefficient = -0.229, P = 0.001,
r2 = 0.079).
Objective volume symmetry and ‘Satisfaction
with breasts’ sub-question ‘How equal in size your
breasts are to each other?’
Due to the nature of ‘Satisfaction with breasts’ being a
global outcome score, the 3D volume and shape symmetry
were tested against participants’ perceptions using the sub-
questions relating to volume and symmetry.
The median volume symmetry measurements differed
between groups according to patient-reported score for
‘How equal in size your breasts are to each other’ (Kruska-
Wallis test, P\ 0.001). Post hoc pairwise comparison
using Dunn–Sidak test further demonstrated that there were
significant differences between participants’ scores for
equality of size ‘very dissatisfied’ and ‘very satisfied’
(P = 0.046), ‘somewhat dissatisfied’ and ‘somewhat sat-
isfied’ (P = 0.008), ‘somewhat dissatisfied’ and ‘very
satisfied’ (P = 0.006) (Table 4). This indicates that par-
ticipants who were ‘very satisfied’ with how equal in sizeFig. 2 Frequency distribution of volume symmetry
Fig. 3 Frequency distribution of shape symmetry, root mean squared
(RMS)
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their breasts are had significantly better volume symmetry
than those who answered ‘very dissatisfied’ or ‘somewhat
dissatisfied’.
Objective surface symmetry and ‘Satisfaction
with breasts’ sub-question ‘How much your breasts
look the same?’
The median shape symmetry measurements were signifi-
cantly different according to patient-reported score for
‘How much your breasts look the same’ (Kruskal–Wallis
test, P\ 0.001). Post hoc pairwise comparison using
Dunn–Sidak test further demonstrated that these differ-
ences arose between participants’ scores ‘very dissatisfied’
and ‘somewhat satisfied’ (P = 0.017), ‘very dissatisfied’
and ‘very satisfied’ (P\ 0.001), ‘somewhat dissatisfied’
and ‘very satisfied’ (P = 0.002) and ‘somewhat satisfied’
and ‘very satisfied’ (P = 0.002) (Table 4). This indicates
that participants who were ‘very satisfied’ that their breasts
look the same had a greater objective symmetry compared
to participants who rated it as ‘very dissatisfied’, ‘some-
what dissatisfied’ and ‘somewhat satisfied’.
Discussion
This study shows that 3D measures of volume and shape
symmetry agree with panel assessment and to a lesser
extent with PROMs, indicating that 3D surface imaging
could contribute to an objective measure of aesthetic out-
come. Currently, the mainstays of analysis of aesthetic
outcome are panel assessment of 2D photographs and
objective scoring software using 2D photographs. Panel
assessments have limitations in the time and manpower
required. Furthermore, they are difficult to standardise and
there is no assurance that, even if the same scale is used,
two panels would score with identical strictness or
leniency. Objective analysis offers a potential solution but
2D photographs may not provide the ‘whole story’ due to
the very nature of analysing a three-dimensional object in
Table 3 Volume and shape symmetry according to 3D-SI panel scores
Panel assessment consensus scores Number Volume symmetry (%)
median (IQR)
Shape symmetry (RMS)
median (IQR)
1 = Poor 8 85.6 (75.3–90.7) 9.7 (6.5–13.2)
2 = Fair 62 83.1 (72.2–92) 7.9 (6.4–9.8)
3 = Good 78 88.2 (80.6–93.8) 5.2 (4–7.2)
4 = Excellent 52 89.7 (81.3–93.6) 4.6 (3.4–6)
Total 200 87 (78.1–93.4) 5.9 (4.2–8)
Fig. 4 Box and whisker plot demonstrating volume symmetry (%)
according to consensus panel assessment of aesthetic outcome. The
horizontal lines within each box represent median scores, the outer
horizontal lines of each box represent upper and lower quartiles, and
the ends of the vertical lines represent minimum and maximum
scores. On post hoc pair wise comparisons there was a significant
difference in volume symmetry when comparing ‘fair’ with ‘good’
and ‘fair’ with ‘excellent’ panel scores. The other comparisons were
not significant
Fig. 5 Box and whisker plot demonstrating shape symmetry RMS,
mm) according to consensus panel assessment of aesthetic outcome.
The horizontal lines within each box represent median scores, the
outer horizontal lines of each box represent upper and lower quartiles,
and the ends of the vertical lines represent minimum and maximum
scores. On post hoc pair wise comparison there was a significant
difference in shape symmetry when comparing poor with good, poor
with excellent, fair with good and fair with excellent. The other
comparisons were not significant
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two dimensions. For example, 2D photographs do not
demonstrate the projection and cleavage well, whereas in
3D-SI, the image of the patient can be rotated to view the
cleavage and allow the reviewer to see the patient as she
sees herself.
Patients also provide insight into their own assessment
of the aesthetic outcome with PROMs, and this is a key
outcome measure. However, there may be many con-
founding factors in the patients’ responses due to their pre-
morbid state and the psychological impact of diagnosis and
treatment of breast cancer such that PROMs alone cannot
be used in evaluation of new surgical or radiotherapy
techniques. We have shown that 3D-SI can contribute to
these evaluations.
In this study, there were only two significant pairwise
comparisons of volume symmetry out of a possible seven
when assessing its relationship with panel assessment. It is
possible that surgery and radiotherapy lift the breast on the
chest wall so that the panel assessment of symmetry is poor
but the objective volume symmetry is relatively good.
Similarly, a patient may have a focal deformity, drawing
the reviewer’s attention resulting in a low panel score but
the overall objective volume is similar to the unaffected
breast. Finally, the low association found between panel
and volume symmetry may also have been due to the panel
method used as the Harvard classification focuses on
symmetry and deformity of the breasts rather than volume.
There was a better association between objective shape
symmetry and panel score with four significant pairwise
comparisons. Shape symmetry encompasses volume as part
of the whole, just as a panel will evaluate appearance more
globally and the Harvard score focuses on symmetry so it is
unsurprising that there was a better association with shape
than with volume symmetry. Our findings are in keeping
with those of Henseler et al. [38] who found a significant
relationship between the mean subjective panel assessment
score and objective symmetry (correlation coefficient
-0.62) when assessing forty-four patients who had
undergone unilateral extended latissimus dorsi flap
reconstruction.
Volume symmetry and shape symmetry were both cor-
related with patient ‘Satisfaction with breasts’. However,
these correlations were weak such that these objective
measurements are unlikely to replace a patient’s perception
of aesthetic outcome. The patient satisfaction domain of
the BREAST-Q encompasses many aspects of how the
patient feels about the aesthetic outcome and, as mentioned
previously, many biases can confound a patients’ satis-
faction other than pure aesthetic outcome. These results
may also reflect the way in which the BREAST-Q module
was developed and it could be that volume and symmetry
had low weighting in the overall scoring compared to other
factors, for example, how the patient feels about her
appearance unclothed. To assess this further, we investi-
gated the relationship between the sub-question ‘How
equal in size your breasts are to each other’ and volume
symmetry. There were three significant pairwise compar-
isons indicating that patients’ subjective assessment on a
4-point scale correlates well with objective assessment of
volume symmetry. Sub-question ‘How much your breasts
look the same’ demonstrated even better association with
shape symmetry, with four pairwise comparisons. A similar
study was undertaken by Yip et al. [39] where 119 women
who had undergone immediate or delayed breast recon-
struction underwent 3D-SI and answered the BREAST-Q
post-operative reconstruction module. Unlike this study,
they found no correlation between volume symmetry and
‘Satisfaction with breasts’ but they did find that patients
were able to perceive volume difference on answering the
sub-questions. The authors did not assess shape symmetry.
The heterogeneity of their patient population may account
for the difference in results between their study and ours.
We believe that 3D-SI will have an important role in the
evaluation of breast surgery and radiotherapy in the future.
As the technology evolves to become more portable and
lower cost, [40–44] it will be available to more units
Table 4 Volume symmetry according to ‘How equal in size your breasts are to each other?’ and shape symmetry according to ‘How much your
breasts look the same?’
Sub-question Likert scale With your breasts in mind, in the past 2 weeks, how satisfied or dissatisfied have you been with:
How equal in size your breasts are to each other? How much your breasts look the same?
Number Median volume symmetry (%)
median (IQR)
Number Median shape symmetry
(RMS) median (IQR)
1 = Very dissatisfied 11 78.1 (71.1–82.3) 13 7.8 (7.2–10.4)
2 = Somewhat dissatisfied 41 79.9 (69.8–89.4) 40 6.4 (4.6–9.1)
3 = Somewhat satisfied 87 89 (81.7–93.8) 93 6.1 (4.6–8.1)
4 = Very satisfied 61 89.8 (80.9–93.6) 54 4.6 (3.4–6.3)
Total 200 87 (78.1–93.4) 200 5.9 (4.2–8)
Breast Cancer Res Treat (2017) 164:385–393 391
123
treating patients with breast cancer, and could be used as a
robust outcome tool in multicentre surgical and radiother-
apy studies as well as in internal audits and quality assur-
ance studies.
Conclusion
Breast volume and shape symmetry measured using 3D-SI
are both associated with panel assessment of breast
appearance and patient satisfaction with the cosmetic out-
come. Shape symmetry, in particular, showed greatest
association with panel assessment, such that it may be
possible to replace this with an objective outcome score
encompassing shape symmetry and other parameters
measured using 3D-SI.
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